The AMNOG monitor provides price trends for all medicinal products subject to early benefit assessments since the G-BA resolution. Effective reimbursement prices and price disocunts since launch are calculated from the respective manufacturer's selling prices (Abgabepreis des pharmazeutischen Unternehmers; APU) minus mandatory rebate acc. to § 130a SGB V excluding VAT for the largest pack of the greatest strength.
All price changes since launch until today can be found in the individual analysis for every AMNOG product. You can also see the effective reimbursement prices, prices/year and the corresponding relative rebates or premiums before / after the reimbursement price negotiation in the Interactive analysis, which offers extensive additional filtering and analytical functions. more >>